ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 159 filers reported holding ARCELLX INC in Q4 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $240,000 | +166.7% | 4,347 | +237.0% | 0.00% | – |
Q1 2024 | $90,000 | -86.5% | 1,290 | -89.2% | 0.00% | – |
Q4 2023 | $665,000 | +271.5% | 11,974 | +140.4% | 0.00% | – |
Q3 2023 | $179,000 | +92.5% | 4,980 | +68.2% | 0.00% | – |
Q2 2023 | $93,000 | +78.8% | 2,960 | +74.1% | 0.00% | – |
Q1 2023 | $52,000 | -49.5% | 1,700 | -49.3% | 0.00% | – |
Q4 2022 | $103,000 | +1187.5% | 3,353 | +746.7% | 0.00% | – |
Q3 2022 | $8,000 | -90.6% | 396 | -91.5% | 0.00% | – |
Q2 2022 | $85,000 | +286.4% | 4,676 | +199.9% | 0.00% | – |
Q1 2022 | $22,000 | – | 1,559 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
CAXTON CORP | 36,302 | $1,124,640 | 2.87% |